TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26497946

Group type: EXPERIMENTAL
Intervention: Single‐incision robotic cholecystectomy (SIRC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classic four‐port laparoscopic cholecystectomy (CLC)
Number of subjects: 60
Study: 24444847

Group type: EXPERIMENTAL
Intervention: SHARP-at work intervention
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 158
Study: 21532737

Group type: EXPERIMENTAL
Intervention: High dose intravenous methylprednisolone (1 g) followed by oral prednisolone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral prednisolone alone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (methylprednisolone + oral prednisolone and oral prednisolone alone)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 19630506

Group type: EXPERIMENTAL
Intervention: TEA combined with general anesthesia (TEA group, n = 36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: General anesthesia (GA group, n = 36)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: TEA combined with general anesthesia (TEA group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: General anesthesia (GA group)
Number of subjects: 72
Study: 16253403

Group type: EXPERIMENTAL
Intervention: Multi-fibre-enriched formula (15 g/l)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Fibre-free formula
Number of subjects: 15
Study: 15319700

Group type: EXPERIMENTAL
Intervention: Unkei-to
Number of subjects: 24

Group type: COMPARATOR
Intervention: Toki-shakuyaku-san
Number of subjects: 24
Study: 10902879

Group type: EXPERIMENTAL
Intervention: Palletization with different headroom conditions
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Recovery phase with different headroom conditions
Number of subjects: 21
Study: 9495662

Group type: EXPERIMENTAL
Intervention: Captopril-based treatment
Number of subjects: 11019

Group type: COMPARATOR
Intervention: Conventional antihypertensive therapy (diuretics and/or beta-blockers)
Number of subjects: 11019
Study: 8095949

Group type: EXPERIMENTAL
Intervention: Full mask worn
Number of subjects: 30

Group type: COMPARATOR
Intervention: No mask worn
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mask placement below the nose
Number of subjects: 30
Study: 2939666

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (A (H3N2) + A (H1N1), 3.0‐3.4 micrograms of hemagglutinin per 0.2 ml)
Number of subjects: 6928

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6928
Study: 4549504

Group type: EXPERIMENTAL
Intervention: Teasing of skin snips
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-teasing methods of skin snips
Number of subjects: 0
Study: 31133099

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (700 U) and 100 mg of calcium
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (100 U of Vitamin D and 100 mg of calcium)
Number of subjects: 101
Study: 27857024

Group type: EXPERIMENTAL
Intervention: LV5FU2
Number of subjects: 62

Group type: COMPARATOR
Intervention: FOLFOX
Number of subjects: 62
Study: 25305637

Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 386

Group type: COMPARATOR
Intervention: Conventional physical education classes
Number of subjects: 386
Study: 22552359

Group type: EXPERIMENTAL
Intervention: Goserelin 3-month depot (Direct Group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goserelin 1-month depot followed by 3-month depot (Switch Group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (Direct and Switch)
Number of subjects: 0
Study: 21680862

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (HME)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No heat and moisture exchanger (HME)
Number of subjects: 30
Study: 19947273

Group type: EXPERIMENTAL
Intervention: Tuina treatment on ten points using thumb and middle finger
Number of subjects: 240

Group type: COMPARATOR
Intervention: Medication group (oral Chlorpheniramine and topical zinc oxide ointment or Youzhuoer ointment)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Tuina treatment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Medication group
Number of subjects: 240
Study: 16924568

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide (NB) 4 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Systemic corticosteroid (SC) 1 mg/kg/day methylprednisolone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide (NB) plus systemic corticosteroid (SC)
Number of subjects: 30
Study: 15575855

Group type: EXPERIMENTAL
Intervention: Ovide (0.5% malathion) for 20 minutes
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nix (1% permethrin)
Number of subjects: 41
Study: 11606016

Group type: EXPERIMENTAL
Intervention: FAST
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SLOW
Number of subjects: 20

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 20
Study: 9075036

Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (HTE) with 2% lidocaine 5 ml
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low thoracic epidural anesthesia (LTE)
Number of subjects: 24
Study: 8503338

Group type: EXPERIMENTAL
Intervention: Flutamide 125 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 750 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 1125 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 1500 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg/day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide 1500 mg/day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flutamide (various doses)
Number of subjects: 26
Study: 3100110

Group type: EXPERIMENTAL
Intervention: 4 IU hGH, subcutaneously, 12-hourly for 72 hours before GHRH test
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 4 IU hGH, single subcutaneous dose, 12 hours before GHRH test
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 IU hGH, intravenously, followed by i.v. GHRH 3 hours later
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo, subcutaneously, 12-hourly for 72 hours before GHRH test
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo, intravenously, followed by i.v. GHRH 3 hours later
Number of subjects: 14
Study: 27637735

Group type: EXPERIMENTAL
Intervention: Cognitive-Functional (Cog-Fun) intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (received treatment after crossover)
Number of subjects: 107
Study: 29408304

Group type: EXPERIMENTAL
Intervention: Automated prompts
Number of subjects: 27000

Group type: EXPERIMENTAL
Intervention: Live prompts
Number of subjects: 27000

Group type: EXPERIMENTAL
Intervention: Combination of automated plus live prompts
Number of subjects: 27000

Group type: COMPARATOR
Intervention: Direct-mail fecal immunochemical testing (FIT) program
Number of subjects: 27000
Study: 27226262

Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses (BB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (clear glasses)
Number of subjects: 32
Study: 24738550

Group type: EXPERIMENTAL
Intervention: Team context (three-person teams)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Individual context
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both contexts (team and individual)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Team context (for students with pre-test scores ≤25.8%)
Number of subjects: 78
Study: 23748185

Group type: EXPERIMENTAL
Intervention: High-frequency exercise group (HF-EG)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Low-frequency exercise group (LF-EG)
Number of subjects: 162
Study: 20601162

Group type: EXPERIMENTAL
Intervention: Afrocentric identity group
Number of subjects: 560

Group type: COMPARATOR
Intervention: Non-Afrocentric identity group
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Afrocentric participants
Number of subjects: 560
Study: 17595176

Group type: EXPERIMENTAL
Intervention: Web-based individualized precontemplation feedback (PCF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based individualized contemplation feedback (CF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based individualized action feedback (AF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16483391

Group type: EXPERIMENTAL
Intervention: Low-dose, high-concentration localized botulinum toxin A (BTX-A) injections (total dose 82-220 units, mean 139 [SD 37.48]; dilution 100 units/0.5ml)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low-dose, high-concentration localized botulinum toxin A (BTX-A) injections
Number of subjects: 42
Study: 15363241

Group type: EXPERIMENTAL
Intervention: Warming group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study: 11194696

Group type: EXPERIMENTAL
Intervention: Sponsor kit of promotional materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthway staff attendance
Number of subjects: 0
Study: 9139168

Group type: EXPERIMENTAL
Intervention: Interval exercise training on cycle ergometer (IntCT) with 30‐s work phases/60‐s recovery phases and on treadmill with 60‐s work and recovery phases each for 3 weeks.
Number of subjects: 18
Study: 8440356

Group type: EXPERIMENTAL
Intervention: ABO‐identical platelets
Number of subjects: 40

Group type: COMPARATOR
Intervention: ABO‐unmatched platelets
Number of subjects: 40
Study: 4027872

Group type: EXPERIMENTAL
Intervention: PALA alone (800 to 1000 mg/m2 per day for 5 days every 2 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: PALA + 5-FU (PALA: 400 mg/m2 per day for 5 days, 5-FU: 300 mg/m2 per day for 5 days every 28 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: 5-FU alone (300 to 400 mg/m2 per day for 5 days every 21 days)
Number of subjects: 63
Study: 30513988

Group type: EXPERIMENTAL
Intervention: Juçara supplementation (5 g juçara freeze-dried pulp)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (5 g of maltodextrin)
Number of subjects: 27
Study: 27263403

Group type: EXPERIMENTAL
Intervention: Maternal Hb concentration ≤109 g/L during 24-28 weeks of gestation
Number of subjects: 17193

Group type: EXPERIMENTAL
Intervention: Maternal Hb concentration 120-129 g/L during 24-28 weeks of gestation
Number of subjects: 17193

Group type: EXPERIMENTAL
Intervention: Maternal Hb concentration ≥130 g/L during 24-28 weeks of gestation
Number of subjects: 17193
Study: 24631162

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent
Number of subjects: 2332

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent
Number of subjects: 2332
Study: 22723003

Group type: EXPERIMENTAL
Intervention: AA genotype
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: AC+CC genotype
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: A allele frequency
Number of subjects: 320
Study: 20466223

Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg
Number of subjects: 68

Group type: COMPARATOR
Intervention: Meperidine 1 mg/kg
Number of subjects: 68
Study: 18652922

Group type: EXPERIMENTAL
Intervention: Contraction Stress Test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonstress Test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vibroacoustic Stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amniotic Fluid Volume Assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biophysical Profile
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Biophysical Profile
Number of subjects: 0
Study: 16188816

Group type: COMPARATOR
Intervention: Implementation package alone (group A)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Implementation package and visits from a facilitator (group B)
Number of subjects: 34
Study: 12811420

Group type: EXPERIMENTAL
Intervention: (99m)Tc-TOC scintigraphy
Number of subjects: 32
Study: 10232312

Group type: EXPERIMENTAL
Intervention: co‐trimoxazole (800 mg/160 mg)
Number of subjects: 771

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 771
Study: 8923159

Group type: EXPERIMENTAL
Intervention: Reduced-fat products
Number of subjects: 217

Group type: COMPARATOR
Intervention: Full-fat products
Number of subjects: 217
Study: 1987739

Group type: EXPERIMENTAL
Intervention: Intracavitary brachytherapy boost (10-15 Gy) following external beam radiation therapy (60-64 Gy).
Number of subjects: 146

Group type: COMPARATOR
Intervention: External beam radiation therapy alone (65-70 Gy).
Number of subjects: 146
Study: 6132178

Group type: EXPERIMENTAL
Intervention: Meptazinol, 300-500 mg intravenously
Number of subjects: 24

Group type: COMPARATOR
Intervention: Naloxone, 30-40 mg intravenously
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-dose corticosteroids
Number of subjects: 24
Study: 31706337

Group type: EXPERIMENTAL
Intervention: Neoadjuvant stereotactic radiosurgery (SRS)
Number of subjects: 72
Study: 29353631

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate 5% aqueous solution (double dose)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chlorhexidine 0.12%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plantago major extract
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study: 25420791

Group type: EXPERIMENTAL
Intervention: XIENCE EES (everolimus-eluting stents)
Number of subjects: 64

Group type: COMPARATOR
Intervention: BioMatrix BES (biolimus A9-eluting stents)
Number of subjects: 64
Study: 25443604

Group type: EXPERIMENTAL
Intervention: Modified radial approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Modified Cox's Maze III
Number of subjects: 80
Study: 22938716

Group type: COMPARATOR
Intervention: Budesonide 400 μg daily
Number of subjects: 943

Group type: COMPARATOR
Intervention: Nedocromil 16 mg daily
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoids (higher doses in first 2 years)
Number of subjects: 943
Study: 20539303

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) providing 800‐1,000 kcal/day during 8 weeks
Number of subjects: 701
Study: 18265850

Group type: EXPERIMENTAL
Intervention: Pound of lead
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pound of feathers
Number of subjects: 0
Study: 15730557

Group type: EXPERIMENTAL
Intervention: Artesunate plus Sulfadoxine/Pyrimethamine (AS+SP)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Artesunate plus Amodiaquine (AS+AQ)
Number of subjects: 269
Study: 12784695

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM) practices in stroke management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke Unit (SU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guidelines for acute stroke management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke Scales
Number of subjects: 0
Study: 9849415

Group type: EXPERIMENTAL
Intervention: Oral contraceptive users
Number of subjects: 422

Group type: COMPARATOR
Intervention: Non-oral contraceptive users
Number of subjects: 422
Study: 8520707

Group type: EXPERIMENTAL
Intervention: Vitamin E, Vitamin C, Beta-carotene
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000
Study: 2152803

Group type: EXPERIMENTAL
Intervention: 0.5 mg oral solution
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.5 mg tablet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 5 mg tablet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.5 mg intravenous infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All oral doses
Number of subjects: 8
Study: 380912

Group type: EXPERIMENTAL
Intervention: Levamisole (2.0 to 2.5 mg per kg body weight, single dose on 1 day per week for 4 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31658134

Group type: EXPERIMENTAL
Intervention: Nicorandil therapy (nicorandil 10 mg three times daily plus hydration)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional treatment (hydration only)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Nicorandil therapy
Number of subjects: 300
Study: 31056733

Group type: EXPERIMENTAL
Intervention: cilostazol (200 mg/day)
Number of subjects: 415

Group type: COMPARATOR
Intervention: aspirin (100 mg/day)
Number of subjects: 415
Study: 28062625

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin I (hs-TnI) >26 ng/L
Number of subjects: 15833

Group type: COMPARATOR
Intervention: High-sensitivity troponin I (hs-TnI) <1.9 ng/L
Number of subjects: 15833

Group type: EXPERIMENTAL
Intervention: Vorapaxar in patients with hs-TnI >26 ng/L
Number of subjects: 15833

Group type: COMPARATOR
Intervention: Vorapaxar in patients with hs-TnI <1.9 ng/L
Number of subjects: 15833
Study: 26440235

Group type: EXPERIMENTAL
Intervention: Propofol at a rate of 120 mcg/kg/min starting immediately after CPB and maintained throughout surgery and for 6 hours in ICU
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propofol at a dose of 30-50 mcg/kg/min starting at chest closure and continued for 6 hours in ICU
Number of subjects: 24
Study: 24337339

Group type: EXPERIMENTAL
Intervention: Antistigma photovoice intervention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 82
Study: 20661160

Group type: EXPERIMENTAL
Intervention: Interval Training (IT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 21
Study: 19309331

Group type: EXPERIMENTAL
Intervention: ADHD in the proband
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: PSUD in the proband
Number of subjects: 123

Group type: COMPARATOR
Intervention: ADHD and PSUD in probands
Number of subjects: 123
Study: 17688011

Group type: EXPERIMENTAL
Intervention: Enriched Intervention (EI)
Number of subjects: 1553

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 1553
Study: 15906019

Group type: EXPERIMENTAL
Intervention: Tramadol-HCl 100 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tramadol-HCl 150 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tramadol-HCl 50 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 12270852

Group type: EXPERIMENTAL
Intervention: Sitaxsentan (selective ET(A) receptor antagonist) infused at increasing rates (0.3125 to 10 mg/min) in patients with HF
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sitaxsentan (selective ET(A) receptor antagonist) infused in control subjects
Number of subjects: 12
Study: 9638665

Group type: EXPERIMENTAL
Intervention: Various chemotherapy protocols (SIOP 1, SIOP 2, HDMTX/VCR, HIT protocol 89/91, Carbo-PEI)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: HIT protocol 89/91 as first-line treatment
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard treatment (surgery and radiotherapy alone)
Number of subjects: 46
Study: 7990463

Group type: EXPERIMENTAL
Intervention: Experimental expectancy modification condition (10-minute video intervention)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control condition (10-minute video presenting facts about alcohol's deleterious effects)
Number of subjects: 268

Group type: COMPARATOR
Intervention: No-intervention control condition
Number of subjects: 268
Study: 2538960

Group type: EXPERIMENTAL
Intervention: Surgery + Radiation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Radiation
Number of subjects: 71
Study: 30018166

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention using quality improvement and chronic care model approaches to improve delivery of penicillin prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative evaluation through interviews and observations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Action items developed by clinic staff with project officers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Later stages of the study
Number of subjects: 0
Study: 27447160

Group type: EXPERIMENTAL
Intervention: Test implant system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Predicate implant system
Number of subjects: 120
Study: 25197812

Group type: EXPERIMENTAL
Intervention: Intravenous bolus of normal saline (22 mL/kg body weight) after sleep onset with compression stockings to prevent fluid accumulation in the legs.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normal saline infusion to keep the vein open (control arm).
Number of subjects: 17
Study: 24373251

Group type: EXPERIMENTAL
Intervention: FOLFIRI3-bevacizumab
Number of subjects: 61
Study: 20961386

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel (CHX-Gel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouthwash (CHX-MW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine dentifrice-gel (CHX-DFG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular dentifrice (RDF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CHX-DFG and RDF
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% CHX-Gel and 0.2% CHX-MW
Number of subjects: 0
Study: 18381138

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Beta-blockers
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Antiplatelet drugs
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Statin use, beta-blockers, antiplatelet drugs
Number of subjects: 1404
Study: 16763088

Group type: EXPERIMENTAL
Intervention: Transbond Plus Self‐Etching Primer (SEP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Conventional separate two‐step etch and primer system
Number of subjects: 39
Study: 14567873

Group type: EXPERIMENTAL
Intervention: Automated feedback system comments on non-adherence to guidelines
Number of subjects: 24
Study: 11295903

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 81)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (n = 36)
Number of subjects: 117
Study: 9140517

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with standardized extracts of Dermatophagoides pteronyssinus and D. farinae
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study: 8186117

Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intralesional triamcinolone
Number of subjects: 0